PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Alcon to buy Aerie Pharmaceuticals for $770M

Eye care drug company Alcon and Aerie Pharmaceuticals have entered a definitive merger agreement through which Alcon will acquire Aerie for $770 million.

The acquisition will give Alcon access to Aerie’s marketed fixed-dose kinase inhibitors, Rocklatan and Rhopressa, as well as other clinical and preclinical ophthalmic pharmaceutical products. In exchange, Aerie will receive $15.25 per share, a premium of 37% to the last closing price.

Alcon’s CEO David Endicott says the company is looking forward to joining forces. “Aerie is a natural fit with on-market and pipeline products, and R&D capabilities that offer the infrastructure needed to expand our ophthalmic pharmaceutical presence. As we continue to broaden our portfolio across glaucoma, retina, and ocular surface disease, we are excited to help even more patients see brilliantly.”

Most recently, Aerie’s financial guidance for its total glaucoma franchise net product revenue totalled $130-$140 million for 2022. Alcon, based in Switzerland, profited $8.2 billion in 2021 with a net income of $1.1 billion.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026